글로벌 요관암 치료 시장 – 2029년까지의 산업 동향 및 예측

요관암 치료 시장 분석 및 규모

글로벌 요관암 치료 시장은 예측 기간 동안 상당한 성장을 보일 것으로 예상됩니다. 전 세계 주요 경제권에서 요관암 사례가 증가하는 것은 요관암 치료 시장의 중요한 성장 원동력입니다. 또한, 요관암에 걸리기 쉬운 노령 인구가 증가함에 따라 향후 몇 년 동안 요관암 치료 시장 성장이 촉진될 수 있습니다. COVID-19도 시장 성장에 큰 영향을 미쳤습니다.

Data Bridge Market Research는 2022-2029년 예측 기간 동안 글로벌 요관암 치료 시장의 성장률을 분석합니다. 시장 가치, 성장률, 시장 세그먼트, 지리적 범위, 시장 참여자, 시장 시나리오와 같은 시장 통찰력 외에도 Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석, 규제 프레임워크도 포함됩니다.

요관암 치료 시장 범위 및 세분화

Market Definition

Ureter cancer treatment is also known as renal pelvis, that is characterized by abnormal growth of abnormal cells that line the inside of the tubes. This type of cancer generally affects men above the age of 65 years and more. Chronic irritation in the kidney has been recognised as one of the main causes of ureter cancer. Some of the factors causing the irritation includes continuous smoking and analgesic nephropathy. 

Global Ureter Cancer Treatment Market Dynamics

Drivers

• Increased Incidence of Ureter Cancer

Ureter cancer is a malignant neoplasm arising from urothelium. The disease is the ninth most common malignancy in the world, with around 2.5 million patients and 420,000 newly diagnosed cases every year. Bladder transitional cell carcinoma (TCC) accounted for around 90% of all urinary cancer cases.Thus, it boosts the market growth.

• Adoption of Multiple Growth Strategies

The global ureter cancer treatment market is competitive, with the presence of many well-established players. Many of these market players could adopt several growth strategies such as novel product launches, to remain competitive in the overall market. For instance, in 2019, Pfizer received the approval from the FDA for the drug BAVENCIO Plus Inylta, which has proven to be beneficial in treating patients in the last few years.

Opportunities

• Increased Government Funds

The ureter cancer treatment market players will seek investments from governments and private investors, which could help them in their long-term growth. These players could organize the funding in research and development activities to produce improved quality of products, which would meet the requirements of huge customers and help increase their consumer base.Thus, all these factors enhance the market expansion.

• Rise in Elderly Population

The rising global elderly population is a main factor boosting the market growth. As per the World Health Organization, the population of people aged over 60 years is projected to be 1.4 billion in 2020. Furthermore, in 2050, this number is anticipated to reach 2.1 billion. This factor is expected to create opportunities in the forecast period.

• Greater Adoption of Immunotherapy

The rising potential of immunotherapies to be used in adjuvant and neoadjuvant settings is now the primary subject of several clinical trials. These treatments will be combined with standard therapies to provide patients with safer and more effective treatment options. Innovative treatments such as CAR-T therapies and viral therapy continue to produce interest as a potential treatment of ureter cancer.

 Restraints/Challenges

• Side Effects of Ureter Cancer Drugs

The side effects associated with these ureter cancer drugs could limit the growth of the global ureter cancer market over a forecast period. Effects such as loss of appetite, fever, rashes, fatigue, constipation, bleeding can hamper the market growth.

• Lack of Skilled Professionals

The lack of healthcare professionals who are unable to diagnose the condition and treat the same can hamper the market growth. Trained professionals are required for faster identification of the disease and immediate treatment process so that the recovery can be faster.

This global ureter cancer treatment market  report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global ureter cancer treatment market  contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In April 2022, Pfizer made an equity investment in Zentalis Pharmaceuticals, Inc. worth USD 25 million. This investment is anticipated to benefit Pfizer to leverage its development capabilities worldwide.
• In May 2022, Pfizer made a research collaboration agreement with NetVation DL Medicine for two years. This collaboration is predicted to assist and advance Pfizer in its research activities.
• In June 2022, Roche launched a human papillomavirus (HPV) self-sampling solution that allows patients to perform HPV screening in the presence of a healthcare worker. This is anticipated to expand the company’s cancer screening solution line-up.

Global Ureter Cancer Treatment Market Scope

The global ureter cancer treatment market  is segmented on the basis of treatment, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Treatment

• Ureterectomy
•  Chemotherapy
• Radiation
• Others

Route of Administration

• Oral
• Parenteral

End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Ureter Cancer Treatment Market Regional Analysis/Insights

The global ureter cancer treatment market  is analysed and market size insights and trends are provided by treatment, route of administration, distribution channel and end-user as referenced above.

글로벌 요관암 치료 시장 보고서에서 다루는 주요 국가  는 북미의 미국, 캐나다 및 멕시코, 독일, 프랑스, ​​영국, 네덜란드, 스위스, 벨기에, 러시아, 이탈리아, 스페인, 터키, 유럽의 기타 유럽 국가, 중국, 일본, 인도, 한국, 싱가포르, 말레이시아, 호주, 태국, 인도네시아, 필리핀, 아시아 태평양(APAC)의 기타 아시아 태평양(APAC), 사우디 아라비아, UAE, 남아프리카 공화국, 이집트, 이스라엘, 중동 및 아프리카(MEA)의 일부인 기타 중동 및 아프리카(MEA), 브라질, 아르헨티나, 남미의 일부인 기타 남미입니다.

아시아 태평양 지역은 정부 주도의 정책 강화와 의료 시설 개발로 인해 예상 기간 내내 요관암 치료 시장이 가장 높은 성장을 보일 것으로 예상됩니다.

북미는 요관암 발병률이 증가하고, 요관암 치료에 대한 인식이 높아지고, 의료 시설이 발달함에 따라 시장을 장악하고 있습니다.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 또한 글로벌 브랜드의 존재와 가용성, 그리고 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 국내 관세 및 무역 경로의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.   

경쟁 환경 및 글로벌 요관암 치료 시장 점유율 분석

글로벌 요관암 치료 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우세입니다. 제공된 위의 데이터 포인트는 글로벌 요관암 치료 시장과 관련된 회사의 초점에만 관련이 있습니다.

글로벌 요관암 치료 시장에서 활동하는 주요 기업은 다음과 같습니다.

• 파이저 주식회사(미국)
• 아스트라제네카(영국)
• 브리스톨-마이어스 스퀴브 회사(미국)
• Allergan,Inc (아일랜드)
• Dr. Reddy's Laboratories Ltd(인도)
• 엔도 인터내셔널 주식회사(아일랜드)
• Teva Pharmaceutical Industries Ltd(이스라엘)
• Sun Pharmaceutical Industries Ltd(인도)
• 마일런 NV(미국)
• 노바티스 AG(스위스)
• 루팡(인도)
• Cipla Inc(인도)
• Aurobindo Pharma(인도)
• Fresenius SE & Co. KGaA(독일)
• 사노피(프랑스)
• 다케다제약 주식회사(일본)
• F. 호프만-라 로슈 유한회사(스위스)
• 애벗(미국)

SKU-54244